Retrospective Evaluation of the Frequency of Acute Pancreatitis in Adult Hospitalized Patients with COVID-19 Infection

dc.contributor.authorElik, Dilsah Baskol
dc.contributor.authorOruc, Nevin
dc.contributor.authorGuler, Ezgi
dc.contributor.authorErdem, Huseyin Aytac
dc.contributor.authorAkarca, Funda Karbek
dc.contributor.authorSipahi, Oguz Resat
dc.contributor.authorOzutemiz, Ahmet Omer
dc.date.accessioned2024-08-25T18:48:28Z
dc.date.available2024-08-25T18:48:28Z
dc.date.issued2022
dc.departmentEge Üniversitesien_US
dc.description.abstractIntroduction: Data on the relationship between Coronavirus disease-2019 (COVID-19) and acute pancreatitis are limited. This study aimed to investigate the possible role of COVID-19 in the etiology of acute pancreatitis in a tertiary-care educational university hospital by retrospectively evaluating the incidence of acute pancreatitis in adult hospitalized patients with COVID-19. Materials and Methods: Severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV-2) polymerase chain reaction (PCR)-positive adult inpatients from March 15, 2020, to February 1, 2021, constituted the study group in our hospital. This cohort was analyzed for acute pancreatitis criteria, including acute abdominal pain, increased amylase and/or lipase more than three times the normal value, and radiological finding supporting the disease. Patients who met at least two of the acute pancreatitis diagnostic criteria were determined, and those who met the criteria during or after SARS-CoV-2 PCR positivity detection were included in the study. These patients were further analyzed for COVID-19-related data and pancreatitis severity status. Results: Our hospital had 1227 inpatients with COVID-19 diagnosis in one year. A total of four cases met the inclusion criteria. Acute pancreatitis rates were detected at 0.3% and 1.07% for all cohorts (n=1227) and the pancreatic enzyme-tested group (n=372), respectively. Of these four patients, two (50%) were females (50%) and the mean age was 70.7 (range: 64-79) years. There was no correlation between COVID-19 pneumonia and pancreatitis severity scores, including Ranson, Acute Physiologic Assessment and Chronic Health Evaluation 2, and modified computed tomography severity scores. Conclusion: COVID-19 is a rare risk factor for acute pancreatitis and did not affect the pancreatitis severity or mortality in our cohort.en_US
dc.identifier.doi10.4274/mjima.galenos.2022.2022.35
dc.identifier.issn2147-673X
dc.identifier.urihttps://doi.org/10.4274/mjima.galenos.2022.2022.35
dc.identifier.urihttps://hdl.handle.net/11454/102289
dc.identifier.volume11en_US
dc.identifier.wosWOS:000964556200003en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofMediterranean Journal of Infection Microbes and Antimicrobialsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240825_Gen_US
dc.subjectCOVID-19en_US
dc.subjectacute pancreatitisen_US
dc.subjectSARS-CoV-2en_US
dc.subjectClassificationen_US
dc.titleRetrospective Evaluation of the Frequency of Acute Pancreatitis in Adult Hospitalized Patients with COVID-19 Infectionen_US
dc.typeArticleen_US

Dosyalar